|
|
||||||||
1From the Departments of Ophthalmology and 2Neuroscience, University of Florida, Gainesville, Florida.
| Abstract |
|---|
|
|
|---|
METHODS. Pharmacologic reagents were applied to native and transgenic Xenopus tadpoles, to disrupt the microtubules (thiabendazole) and microfilaments (cytochalasin D and latrunculin B) of the rod photoreceptors. Quantitative confocal imaging was used to assess the impact of these treatments on arrestin and transducin translocation. A series of transgenic tadpoles expressing arrestin truncations were also created to identify portions of arrestin that enable arrestin to translocate.
RESULTS. Application of cytochalasin D or latrunculin B to disrupt the microfilament organization selectively slowed only transducin movement from the inner to the outer segments. Perturbation of the microtubule cytoskeleton with thiabendazole slowed the translocation of both arrestin and transducin, but only in moving from the outer to the inner segments. Transgenic Xenopus expressing fusions of green fluorescent protein (GFP) with portions of arrestin implicates the C terminus of arrestin as an important portion of the molecule for promoting translocation. This C-terminal region can be used independently to promote translocation of GFP in response to light.
CONCLUSIONS. The results show that disruption of the cytoskeletal network in rod photoreceptors has specific effects on the translocation of arrestin and transducin. These effects suggest that the light-driven translocation of visual proteins at least partially relies on an active motor-driven mechanism for complete movement of arrestin and transducin.
Functionally, the ROS is primarily responsible for phototransduction, the process of absorbing a photon and converting it to a change in membrane potential. The function of the RIS is essentially to provide the energy demands and cellular building blocks needed to maintain the function of the photoreceptors. However, the line demarcating the functions of the ROS and RIS is somewhat blurred because some components are rapidly translocated between the two segments in a light-dependent manner. Nearly two decades ago, several studies showed that both arrestin and transducin almost completely change their respective compartments in response to light.1 2 3 4 5 In the dark-adapted retina, transducin localizes almost exclusively to the outer segment and arrestin to the inner segment. In response to an adapting light, these proteins translocate in opposite directions, with arrestin moving almost exclusively to the ROS and transducin to the RIS over the course of several minutes.
Studies that first identified the light-driven translocation of arrestin suggested that arrestin translocates to the ROS in the light as a consequence of its binding to light-activated phosphorhodopsin and is thus drawn to the outer segments by mass action.3 However, recent investigations have suggested otherwise. Using transgenic mice that are deficient in rhodopsin phosphorylation (either rhodopsin kinase is knocked out or the C-terminal serine and threonines in rhodopsin are replaced with alanines), researchers showed that arrestin translocates normally to the ROS in response to light, even in rods, where phosphorylation of rhodopsin is blocked, and thus the high-affinity binding partner for arrestin is lacking.6 7 These results suggest that the light-driven translocation of arrestin (and possibly transducin) may use an active motor-driven mechanism, perhaps using the cytoskeleton as molecular "train tracks" on which to move between the RIS and ROS.
In this study, we used Xenopus to investigate more fully the potential involvement of cytoskeletal elements in the light-driven translocation of arrestin and transducin. Using pharmacologic agents and transgenic animals expressing fusions of green fluorescent protein (GFP) to arrestin and portions of arrestin, we present evidence linking the translocation of arrestin to microtubules and the translocation of transducin to both microfilaments and microtubules.
| Methods |
|---|
|
|
|---|
|
Preparation of Transgenic Animals
Transgenic tadpoles were prepared by nuclear transplantation, according to the methodology of Kroll and Amaya,10 with modifications.9 11 Resultant tadpoles were kept in tadpole Ringers solution (10 mM NaCl, 0.15 mM KCl, 0.2 mM CaCl2, and 0.1 mM MgCl2) for 2 to 8 weeks, at which point they were screened visually through the eye to identify tadpoles that were expressing GFP, using blue light to excite emission from the GFP.
Treatment of Tadpoles with Pharmacologic Reagents
Wild-type tadpoles (stages 5054) were obtained from Xenopus Express (Plant City, FL). Tadpoles were placed in tadpole Ringers in the dark overnight. The following day, either cytochalasin D was added to the tank water of the treated animals (25 µM cytochalasin D with 0.25% [vol/vol]) dimethylsulfoxide [DMSO] final concentration), or DMSO was added to the untreated tadpoles (0.25% [vol/vol]) DMSO final concentration). After 6 hours of drug exposure, one set of tadpoles was light adapted for 45 minutes (
800 lux), returned to the dark for 2 hours, and subsequently fixed with 3.7% formaldehyde in 73% methanol. After 8 hours of drug exposure, a second set of tadpoles were exposed to light for 45 minutes and then fixed. A final set of tadpoles was fixed after 8 hours 45 minutes of exposure to the drug in the dark. This regimen was used to ensure that all tadpoles in each lighting condition received the same total time of exposure to cytochalasin D. In all cases, a minimum of three tadpoles was used in each set. This concentration of cytochalasin D was selected because it has been demonstrated to have an effect on disc morphogenesis in Xenopus.12
Another set of tadpoles were treated with latrunculin B (A. G. Scientific, Inc., San Diego, CA) as for the cytochalasin D experiment, except that the final concentration was 200 nM latrunculin in 0.25% (vol/vol) DMSO.
For thiabendazole treatment, transgenic Ar-GFP tadpoles were dark adapted overnight. The following day, thiabendazole was added to the tadpoles (500 µM TB with 2% [vol/vol] DMSO final concentration) or 2% (vol/vol) DMSO added to untreated tadpoles. Tadpoles were exposed to light as described earlier, except that the light-adaptation period was 50 minutes, and the total duration of exposure to thiabendazole before fixation was 7 hours. A minimum of three tadpoles was used in each set. To our knowledge, this is the first reported use of thiabendazole in studying the photoreceptor microtubules. Consequently, we chose this concentration of thiabendazole to be comparable to the micromolar range of colchicine used in other published studies,13 and because it could be delivered to the tadpoles without impairing the survival of the tadpoles for the time course of the experiment.
In all cases, animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and with the approval of the University of Floridas animal care and use committee.
Preparation of Tissue and Confocal Microscopy
Fixed tadpoles were rehydrated through a graded series of methanol in phosphate-buffered saline, equilibrated overnight in 30% sucrose, and then embedded in OCT medium (Sakura FineTek, Torrance, CA). Cryosections (12 µm) were processed for immunocytochemistry as previously described,8 using an anti-arrestin monoclonal antibody (1:50 xAr1-6) and an anti-transducin-
subunit polyclonal antibody (1:100 SC-389; Santa Cruz Biotechnology, Santa Cruz, CA). Both antibodies were specific for the rod antigens, and did not label Xenopus cones. Labeling was detected with an anti-mouseTexas red conjugate (1:100) and an anti-rabbitAlexa Fluor 647 conjugate (1:100; Molecular Probes, Eugene, OR). Nuclei were stained with 300 nM green fluorescent reagent (Sytox green; Molecular Probes). Some sections were also stained with anti-actin polyclonal antibody (1:100, A-2668; Sigma-Aldrich, St. Louis, MO), and with anti-acetylated tubulin monoclonal antibody (1:100, T-6793; Sigma-Aldrich). These antibodies were detected using the same secondary antibodies.
Slides were imaged with a confocal microscope (1024ES; BioRad, Hercules, CA), using laser lines and emission filters optimized for FITC, Texas red, and Cy5. Optical z-sections were collected at 0.5-µm intervals and were subsequently projected in two dimensions.
Image Quantitation
Fluorescence intensity in photoreceptor compartments was quantified as follows. Individual color channels from the confocal TIFF images were gray-scaled with image analysis software (Photoshop 6.0; Adobe Systems, Mountain View, CA) and imported into Scion Image (Scion Image 4.0.2; Scion Corporation, Frederick, MD). Single rod inner and outer segments were then outlined (Fig. 1) , and total fluorescence for the enclosed area was obtained by multiplying the area and average density within the area. The fluorescence in the ROS and RIS was then averaged from a minimum of 12 rods for any given image. For each treatment, average fluorescence in the ROS and RIS was determined for a minimum of two images collected from separate retinal sections from each eye of three animals (n
12). Comparisons were made using Students t-test to establish statistical significance.
|
| Results |
|---|
|
|
|---|
|
-subunit of transducin (Fig. 3) . In untreated tadpoles (Figs. 3A 3B 3C) , transducin localized to the ROS of dark-adapted animals. After a 45-minute light exposure, transducin was visible, filling the RIS. If the animals were subsequently returned to the dark, transducin returned to the ROS, largely evacuating the RIS. In tadpoles treated with cytochalasin D (Figs. 3D 3F) , the localization of transducin was indistinguishable from untreated animals during overnight dark adaptation and 45-minute light adaptation. However, in tadpoles that were returned to the dark after a period of light adaptation, the translocation of transducin from RIS to ROS was significantly slowed (Fig. 3F) . Quantitation of the transducin immunofluorescence shows that this difference is statistically significant (P < 0.01; Fig. 3G ).
|
To demonstrate that application of cytochalasin D in the tank water of the tadpoles is an effective method for supplying the reagent, we immunostained retinal sections with anti-actin, to reveal the microfilaments that surround the ROS. Figure 4 shows that the microfilaments that are normally present in the calycal processes that surround the ROS are absent in the cytochalasin D-treated tadpoles.
|
|
|
|
In Figure 8 we show the effects of removing 10, 20, or 30-amino acids from the C terminus of arrestin in our Ar-GFP fusion. Unlike the previous experiments, after the initial 60-minute light adaptation, tadpoles were kept in the light for an additional 3 hours (4 hours total light adaptation). In Xenopus this lighting condition also promoted translocation of arrestin from ROS to RIS, similar to dark adaptation, as previously documented8 and as demonstrated in Figure 8C . Removing 10 amino acids from the C terminus of arrestin had no effect on the translocation of arrestin for any of the three light conditions (compare Figs. 8A 8B 8C with 8D 8E 8F ). Removing 20 amino acids also had no statistically significant effect on the translocation in either direction, although there appeared to be a trend toward a slowed return of the truncated Ar-GFP to the RIS during DA (Figs. 8G 8H 8I) . The loss of 30 amino acids has a dramatic effect on the localization of arrestin (Figs. 8J 8K 8L) . In the dark-adapted tadpole, Ar(c-30)-GFP is proportionally more localized to the ROS than the RIS. There is some translocation of this truncated arrestin in response to light, but the translocation of this shortened arrestin is considerably slowed, if not halted, in its return to the RIS during extended light adaptation. Replicates of these qualitative observations are also shown quantitatively (Fig. 8M) .
|
Our results indicate that the C terminus of arrestin either contains an element that directly couples arrestin to a light-regulated translocation element, or the C terminus intramolecularly regulates the coupling of arrestin. To determine whether the C terminus is sufficient for translocation, the C-terminal 45 amino acids of arrestin were fused to the N terminus of GFP (C45-GFP), and protein translocation was assessed in vivo in transgenic Xenopus. In this fusion construct, C45-GFP was more highly concentrated in the RIS in DA tadpoles, similar to Ar-GFP (Figs. 9A 9D) . In response to light adaptation for 1 hour, C45-GFP partially redistributed to the ROS, similar to Ar-GFP, although to a smaller extent (Figs. 9B 9E) . During extended light adaptation (4-hour light), Ar-GFP returned to the RIS, whereas the C45-GFP remained in the ROS (Figs. 9C 9F) . In contrast, in tadpoles expressing GFP alone, there was no change in GFP distribution in response to the various lighting conditions (Figs. 9G 9H 9I) . These results clearly show that the C-terminal 45 amino acids of arrestin allow GFP to concentrate in the RIS during dark adaptation and that this localization changes in response to light adaptation, allowing GFP to move into the outer segments.
|
| Discussion |
|---|
|
|
|---|
Clusters of actin microfilaments have been identified in the connecting cilium.19 20 In addition, a myosin motor (myosin VIIa) has been found to be associated with the connecting cilium.21 22 The colocalization of microfilaments and myosin in the connecting cilium and the sensitivity to cytochalasin D of transducin translocation from ROS to RIS suggest that transducin may rely, in part, on a myosin/actin-based mechanism for light-driven movement from the outer segments. In addition, transducin also shows a light-dependent association with phosducin along the length of the rod,23 and with centrin in the connecting cilium.24 How all these pieces fit together to regulate transducin translocation remains unclear.
Treatment of tadpoles with thiabendazole, a benzamidole-class reagent with demonstrated effects on acetylated microtubules16 17 also impacted light-driven protein translocation. Most significantly, thiabendazole treatment dramatically slowed the return of arrestin to the RIS from the ROS during dark adaptation (Fig. 5F) . A slowing of transducin movement in the same direction in response to light adaptation was also observed. As before, the persistence of normal arrestin and transducin translocation from the RIS to the ROS indicates that the effects on protein translocation of treating the tadpoles with thiabendazole is not a consequence of nonspecific clogging of the connecting cilium. Of note, in thiabendazole-treated tadpoles, arrestin quantitatively translocated to the ROS in response to light, but there was a slower dispersion of arrestin in the ROS (Fig. 5H) . This strong basal-to-apical gradient suggests that two separate processes are involveda thiabendazole-insensitive movement of arrestin from the RIS to the ROSfollowed by a thiabendazole-sensitive mechanism that facilitates a more rapid dispersion of arrestin throughout the outer segments.
In rod photoreceptors, microtubules are abundant in both the inner and outer segments. In the RIS, the microtubules are oriented with their plus end toward the endoplasmic reticulum/Golgi complex and their minus ends near the base of the connecting cilium. In the ROS, most of the microtubules are part of the ciliary structure, highly organized as a ring of nine microtubule doublets with their plus ends oriented toward the distal end of the outer segments. Consequently, movement of arrestin from ROS to RIS during dark adaptation, or of transducin from RIS to ROS during light adaptation, presumably involves a minus direction dynein-like motor. In addition to the axonemal microtubules, there are also microtubules running longitudinally that are associated with the incisures along the rim of the outer segments.25 It is tempting to speculate that these microtubules may have a role in facilitating the spread of arrestin throughout the ROS during light adaptation, since thiabendazole treatment leads to a slower dispersion of arrestin in the light-adapted ROS than occurs in untreated control animals.
Our results fit well with recent findings that indicate the rates of translocation for transducin and arrestin are quite different, both during dark adaptation and light adaptation.26 In this study, transducin moves quickly to the RIS in response to light (approximately 2 minutes to completely move from ROS to RIS), but then takes nearly 200 minutes to return to the ROS during dark adaptation. In contrast, arrestin returns to the RIS during 25 minutes of dark adaptation. These different rates are consistent with our results showing an association of transducin with microfilaments and an association of arrestin with microtubules during dark adaptation movements, thus predicting different rates of movements for the two proteins.
We cannot exclude the possibility that treating the tadpoles with the cytoskeletal poisons resulted in nonspecific effects on arrestin and transducin translocation. However, the selectivity of affecting only the movement of transducin and arrestin in one direction (thiabendazole treatment) or affecting only the movement on one protein (cytochalasin D treatment) seemingly argues for relatively specific effects.
Structural Elements in Arrestin Translocation
In this study, we also begin to identify the portion of arrestin that couples to the translocation machinery, which we call here the "translocation domain." Based on previous studies of a splice variant of bovine visual arrestin (p44) that showed a different localization than that of full-length arrestin,18 we targeted the C terminus of arrestin as a potential element in this translocation domain. Using serial truncations of arrestin, we showed that removing the C-terminal 20 amino acids resulted in relatively small perturbations of the arrestin localization. However, removing the C-terminal 30 residues, significantly impacted the translocation, resulting in an arrestin that was more significantly localized to the ROS, and in which the translocation from the outer to the inner segments was dramatically slowed (Fig. 8) . It is important to note that by removing these 30 amino acids, we have not simply created a nonfunctioning aggregate, since the distribution of this misfolded protein would more likely reflect the available cytoplasmic volume, which is approximately 60% RIS/40% ROS.27 Instead, the truncated arrestin has 60% of the fusion localized to the outer segments in the dark-adapted photoreceptors. This truncated arrestin retains some light-driven translocation potential, although the initial translocation of Ar(c-30)-GFP to the outer segments in response to light adaptation was not as complete as the full-length arrestin, and was actually much more reminiscent of the thiabendazole-treated tadpoles with a strong basal to apical gradient of localization (Figs. 8K 8N) . This result can be interpreted in two ways. It could implicate the C-terminal 30 amino acids as containing at least a portion of the translocation domain. Alternatively, the removal of the C terminus could induce a conformational change in arrestin that prevents the protein from docking efficiently with the translocation machinery. Regardless of the interpretation, it appears that by removing the C terminus of arrestin we affected the interaction of arrestin with the translocation machinery at a similar point as did treatment with thiabendazole.
Our subsequent study using a fusion of the C-terminal 45 amino acids of arrestin with GFP offers evidence that the translocation domain is at the C terminus of arrestin. In this fusion, the C45-GFP protein was localized almost exclusively to the inner segments in dark-adapted tadpoles, and showed significant translocation to the outer segments during light adaptation. The simplest interpretation of these results is that the C-terminal 45 amino acids of arrestin provide a tether that promotes localization in the inner segments, and that this anchor is released during light adaptation. However, these data cannot exclude the possibility that the C terminus of arrestin couples to an active motor-driven process. Regardless of the interpretation, the translocation process obviously occurs much more efficiently in the context of the entire arrestin molecule, suggesting that either the conformation of the 45-amino-acid domain may be different in the whole protein, or that there may be additional portions of the arrestin protein that contribute to this "translocation domain." Further investigations will help refine this domain more precisely. It should be noted that we chose 45 amino acids to use the first ATG codon upstream of the implicated 30-amino-acid C terminus and to provide extra amino acids to allow the peptide to adopt a more native conformation.
The Process of Light-Stimulated Translocation
Is light-stimulated translocation a motor-driven process? The mechanism of arrestin translocation, whether it is diffusion based with different binding partners in the ROS and RIS or a motor-assisted process, remains unresolved. Originally, light-stimulated translocation of arrestin was hypothesized to be a passive process, with arrestin localizing to the outer segments in light-adapted eyes based on its affinity for activated, phosphorylated rhodopsin (R*P).3 This hypothesis was brought into question by studies using transgenic mice in which the rhodopsin could not be phosphorylated, thus precluding the formation of arrestins high-affinity binding partner, yet arrestin still translocated normally.6 7 However, a recent study notes that arrestin retains a moderate affinity for activated rhodopsin that is not phosphorylated (R*) and presents evidence that this form of rhodopsin is sufficient to provide a binding sink for arrestin in light-adapted outer segments.28 Further, this study analyzed the rate of diffusion of GFP in rods, showing that equilibrium could be reached between the inner and outer segments in less than 3 minutes, thus concluding that the light-driven translocation of arrestin could be explained by arrestins affinity for R* and R*P in the outer segments of light adapted rods, and by its affinity for microtubules in the inner segments of dark-adapted rods.
Our results can be partially fit into this proposed model. We show a significant reduction in the return of arrestin to the inner segments in the presence of thiabendazole which depolymerizes the inner segment microtubules (see Fig. 7 ). Further, the localization of GFP tagged with the C-terminal 45 amino acids of arrestin to the inner segments of dark-adapted rods could be explained if the C terminus of arrestin, a strongly acidic region, is responsible for conferring an affinity for microtubules. However, the two-sink hypothesis does not completely explain all aspects of our data. For example, our results show that thiabendazole treatment has two effects on arrestin translocation, not only slowing the movement of arrestin to the inner segments during dark adaptation, but also slowing the dispersion of arrestin throughout the outer segments during light adaptation (see Figs. 5E 5H ). Perturbing the microtubules should have no effect on the translocation during light adaptation if arrestin were simply binding to R* or R*P. Similarly, arrestins that are truncated by approximately 30 amino acids also disperse more slowly in light-adapted outer segments (Fig. 8K and Ref. 28 ). A diffusion-mediated process should not be affected by these truncations. Finally, both our results and those of Nair et al.28 show that the truncated arrestins (mouse arrestin 1-377 and Xenopus arrestin 1-366) leave the outer segments and return to the inner segments more slowly during dark adaptation than the full-length arrestins, despite the fact that the truncated arrestin has a higher affinity for microtubules than full-length arrestin.28 29
We also note an additional result in the literature that suggests the two-sink model may not be completely adequate to explain light-driven translocation of arrestin. If arrestin localizes to the inner segments in dark-adapted eyes based on an affinity for microtubules, then the distribution of arrestin in the inner segments should reflect the distribution of microtubules. However, the arrestin distribution in dark-adapted inner segments is rather diffuse (e.g., Refs. 8 ,27 ,30 and Figs. 5A 8A in this study), even though previous studies13 25 31 and this one (Fig. 7) show a strong network of filamentous microtubules in the inner segments. These contradictions of our results by those in published studies with the model of Nair et al.28 suggest that light-driven translocation may require additional elements than have been proposed in the two-sink model. We suggest that arrestin translocation may involve both diffusion-based and active microtubule-based components. It appears that rhodopsin is an important component in retaining arrestin in the outer segments during light adaptation, but also that the complete and rapid dispersion of arrestin throughout the outer segments is facilitated by a microtubule-based system. Furthermore, we propose that the localization of arrestin to the inner segments during dark adaptation cannot be entirely dependent on a direct binding affinity for microtubules. An additional, as yet unidentified, process must regulate the localization of arrestin to the inner segments, and this process must be light dependent.
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
Submitted for publication May 10, 2005; revised July 5, 2005; accepted September 15, 2005.
Disclosure: J.J. Peterson , None; W. Orisme, None; J. Fellows, None; J.H. McDowell, None; C.L. Shelamer, None; D.R. Dugger, None; W.C. Smith, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: W. Clay Smith, Department of Ophthalmology, Box 100284 JHMHC, Gainesville, FL 32610-0284; csmith{at}eye.ufl.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Q. Xi, G. J. T. Pauer, S. L. Ball, M. Rayborn, J. G. Hollyfield, N. S. Peachey, J. W. Crabb, and S. A. Hagstrom Interaction between the Photoreceptor-Specific Tubby-like Protein 1 and the Neuronal-Specific GTPase Dynamin-1 Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Rosenzweig, K. S. Nair, J. Wei, Q. Wang, G. Garwin, J. C. Saari, C.-K. Chen, A. V. Smrcka, A. Swaroop, J. Lem, et al. Subunit Dissociation and Diffusion Determine the Subcellular Localization of Rod and Cone Transducins J. Neurosci., May 16, 2007; 27(20): 5484 - 5494. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Lobanova, S. Finkelstein, H. Song, S. H. Tsang, C.-K. Chen, M. Sokolov, N. P. Skiba, and V. Y. Arshavsky Transducin Translocation in Rods Is Triggered by Saturation of the GTPase-Activating Complex J. Neurosci., January 31, 2007; 27(5): 1151 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Haire, J. Pang, S. L. Boye, I. Sokal, C. M. Craft, K. Palczewski, W. W. Hauswirth, and S. L. Semple-Rowland Light-Driven Cone Arrestin Translocation in Cones of Postnatal Guanylate Cyclase-1 Knockout Mouse Retina Treated with AAV-GC1. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3745 - 3753. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Strissel, M. Sokolov, L. H. Trieu, and V. Y. Arshavsky Arrestin Translocation Is Induced at a Critical Threshold of Visual Signaling and Is Superstoichiometric to Bleached Rhodopsin J. Neurosci., January 25, 2006; 26(4): 1146 - 1153. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||